Neonatal

Kawasaki Disease Criteria

Encodes the AHA 2017 criteria: fever ≥ 5 days plus four or more of five principal clinical features. Captures incomplete Kawasaki disease where 2–3 features prompt further evaluation with echocardiography and inflammatory markers.

01 / Clinical inputsComplete the fields below

Fever ≥ 5 days (or fever and IVIG started before day 5 with classic features)

Bilateral non-exudative conjunctival injection

Oral changes (red lips, strawberry tongue, pharyngeal injection)

Cervical lymphadenopathy ≥ 1.5 cm (usually unilateral)

Polymorphous rash

Extremity changes (erythema/edema acutely; periungual peeling subacutely)

The original source

McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017.

PMID 28356445 Ask House about this

The clinical toolkit

Clinical calculators.

Clinical scoring at the point of care. Validated algorithms, original published sources, mobile-first.